Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2020 June;111(3) > Minerva Medica 2020 June;111(3):285-8

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Minerva Medica 2020 June;111(3):285-8

DOI: 10.23736/S0026-4806.19.06185-8

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Acetyl-11-keto-β-boswellic acid alleviates myocardial fibrosis injury by inhibiting the TGF-β1/Smads pathway and activating the Nrf2/HO-1 pathway

Xiyan HOU 1, Bingfeng GAO 2, Qingtao HAN 3, Qing WANG 4, Haiyang LIANG 5, Qianqian HUO 6

1 Clinical Medicine of Emergency Internal Medicine and Critical Care, Affiliated Hospital of Jining Medical University, Jining, China; 2 Department of Cardiovascular Medicine, the Third People’s Hospital of Linyi, Linyi, China; 3 Department of Vascular Intervention, the People’s Hospital of Zhangqiu Area, Jinan, China; 4 Department of Emergency Internal Medicine, the People’s Hospital of Zhangqiu Area, Jinan, China; 5 Department of Pharmacy, the People’s Hospital of Zhangqiu Area, Jinan, China; 6 Department of Cardiology, Jining No.1 People’s Hospital, Jining, China



top of page